Launch week offerEnds in00h00m00s

annual Promonthly Pro

Yunlong Cao

Has grant

Principal Investigator

Peking University

China

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Recent Grants

Grant: Close

Immune evasion and evolution prediction of SARS-CoV-2

Open Date: 2023-07-01

Close Date: 2024-06-01

Grant: Close

B cell immune responses

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Duration of humoral and cellular immunity induced by COVID-19 vaccines

Open Date: 2021-09-01

Close Date: 2024-09-01

Articles (12)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Andrea Cavalli

Group Leader

Institute for Research in Biomedicine

SWITZERLAND

View details

Michael Hust

Head of department

Technische Universität Braunschweig

GERMANY

View details

Marie Hagbom

Associate Professor

Linköping University

SWEDEN

View details

Josè Camilla Sammartino

Ricercatore (RTDA)

Università degli Studi di Pavia Dipartimento di Scienze Clinico-Chirurgiche Diagnostiche e Pediatriche

ITALY

View details

qiang pan-hammarstrom

Professor, head of the Immunology Division

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yunlong Cao

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (12)

A deep mutational scanning-informed protein language model predicts SARS-CoV-2 evolution dynamics with spatiotemporal resolution

Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV

Safety, tolerability, and pharmacokinetics of anti-SARS-CoV-2 monoclonal antibody SA55 injection in healthy participants

SARS-CoV-2 keeps evolving, so must our research efforts

Deciphering SARS-CoV-2 evolution under antibody immune pressure

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages

The delivery device of SARS-CoV-2 mucosal vaccine matters

Single-cell bisulfite-free 5mC and 5hmC sequencing with high sensitivity and scalability

Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5

Safety and Effectiveness of SA58 Nasal Spray Against COVID-19 Infection in Medical Personnel: An Open-Label, Blank-Controlled Study — Hohhot City, Inner Mongolia Autonomous Region, China, 2022

Collaborators (5)

Andrea Cavalli

Michael Hust

Marie Hagbom

Josè Camilla Sammartino

qiang pan-hammarstrom

Make your next move.